Controversy of TMEM230 Associated with Parkinson's Disease.

Neuroscience
Xiaobo WangWanli W Smith

Abstract

Parkinson's disease (PD) is a common neurodegenerative disease with movement disorders including resting tremor, bradykinesia, rigidity, and postural instability. The key pathological features of PD are selective loss of dopaminergic (DA) neurons in substantial nigra and the presence of Lewy bodies (LBs). Mutations in TMEM230 (transmembrane protein 230) have been recently reported to play a pathological role and contribute to PD pathogenesis. TMEM230 gene encodes two isoforms of TMEM230 proteins, isoform I (183 amino acids) and isoform II (120 amino acids). The function of TMEM230 is not clear, but it may be involved in vesicle trafficking and recycling, autophagy, protein aggregation, and cell toxicity. There are four reported PD-linked TMEM230 mutations (p.Y92C, p.R141L, p.*184Wext*5, p.*184PGext*5). TMEM230-linked PD cases exhibit late-onset, good-response to levodopa, and typical clinical features of sporadic PD with DA neuronal loss in substantial nigra and Lewy body pathology. In this mini review, we recap the current literature of TMEM230 in genetic, neurobiological, and pathological studies in order to further understand the potential roles of TMEM230 in PD pathogenesis.

References

Dec 1, 1996·Journal of Neurocytology·M E CalhounP R Mouton
Oct 13, 2001·Molecular Biology of the Cell·J V Reddy, M N Seaman
Jan 9, 2004·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Vincenzo BonifatiPeter Heutink
Sep 7, 2004·Annals of Neurology·Yasuko HatanoNobutaka Hattori
Nov 16, 2004·Neuron·Coro Paisán-RuízAndrew B Singleton
Jul 19, 2011·American Journal of Human Genetics·Carles Vilariño-GüellMatthew J Farrer
Oct 31, 2015·Current Neuropharmacology·Pilar Rivero-RíosSabine Hilfiker
Jun 9, 2016·Nature Genetics·Han-Xiang DengTeepu Siddique
Nov 7, 2016·Neurobiology of Aging·Weiqian YanZhenhua Liu
Nov 22, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Ya-Chao HeSheng-Di Chen
Nov 23, 2016·Journal of Clinical Movement Disorders·Diana A OlszewskaTim Lynch
Dec 27, 2016·Parkinsonism & Related Disorders·Hauke BaumannChristine Klein
Jan 1, 2017·Parkinsonism & Related Disorders·Hongwei WuWei Luo
Jan 17, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Marialuisa QuadriVincenzo Bonifati
Mar 21, 2017·Parkinsonism & Related Disorders·Gabriele BuongarzoneAlessio Di Fonzo
Mar 23, 2017·Journal of the Neurological Sciences·Xinglong YangYanming Xu
Apr 4, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Xinglong YangYanming Xu
Apr 13, 2017·Frontiers in Cellular Neuroscience·Meng-Meng ShiYu-Ming Xu
Apr 30, 2017·Molecular Neurobiology·Qianqian WeiHui-Fang Shang
May 2, 2017·Neurobiology of Aging·Laura IbanezCarlos Cruchaga
May 21, 2017·Journal of Alzheimer's Disease : JAD·Sandra L SiedlakXinglong Wang
Jun 2, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Wim MandemakersVincenzo Bonifati
Jul 16, 2017·Neurobiology of Aging·Dongrui MaEng King Tan
Jul 25, 2017·Current Neurology and Neuroscience Reports·Andreas Puschmann
Aug 3, 2017·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Tian-Sin FanRuey-Meei Wu
Jan 7, 2018·Parkinsonism & Related Disorders·Silvio A ConederaNobutaka Hattori
May 11, 2018·Journal of Neurochemistry·Theodora SaridakiBjörn H Falkenburger
May 18, 2018·PloS One·Cristina Tejera-ParradoPablo Mir
Jul 30, 2018·Journal of the Neurological Sciences·Radha ProcopioAldo Quattrone
Sep 14, 2018·Proceedings of the National Academy of Sciences of the United States of America·Tomoya EguchiTakeshi Iwatsubo
Sep 25, 2018·Revue neurologique·A LunatiA Brice
Nov 22, 2018·Animal Cells and Systems·Daleum NamWongi Seol
May 30, 2019·Experimental Neurobiology·Wongi SeolIlhong Son
Jul 20, 2019·Journal of the Neurological Sciences·Radha ProcopioAldo Quattrone
Jul 3, 2020·Brain : a Journal of Neurology·Yuwen ZhaoBeisha Tang
Aug 15, 2020·Molecular Genetics & Genomic Medicine·Ran ZhengBao-Rong Zhang
Aug 28, 2020·Frontiers in Aging Neuroscience·Xiaobo WangWanli W Smith

❮ Previous
Next ❯

Citations

May 19, 2021·Human Molecular Genetics·Xiaobo WangWanli W Smith
Jul 3, 2021·Genes·Jacob Oliver Day, Stephen Mullin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Related Papers

Journal of Parkinson's Disease
Hao DengJoseph Jankovic
Neurobiology of Aging
Laura IbanezCarlos Cruchaga
© 2021 Meta ULC. All rights reserved